Patent Yard Sign in
Canadian application, no grantCanada

Lysine-rich statherin protein

CA 2348046 A1 · Owner: Guegler, Karl J. · Inventors: Tang, Y. Tom; Corley, Neil C.; Patterson, Chandra

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides a human lysine-rich statherin protein (LRSP) and polynucleotides which identify and encode LRSP. The invention also provides expression vectors, host cells, antibodies agonists, and antagonists. The , invention also provides methods for diagnosing treating, or preventing , disorders associated with expression of LRSP.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 22, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 22, 1999
GrantedNo grant recorded
Term endedOctober 22, 2019
Patent numberCA 2348046 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedOct 22, 1999Term endedOct 22, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.